Literature DB >> 9863802

Antiretroviral treatment in 1998.

J S Montaner1, R Hogg, J Raboud, R Harrigan, M O'Shaughnessy.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9863802     DOI： 10.1016/S0140-6736(98)07532-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.

Authors:  G P Rizzardi; R J De Boer; S Hoover; G Tambussi; A Chapuis; N Halkic; P A Bart; V Miller; S Staszewski; D W Notermans; L Perrin; C H Fox; J M Lange; A Lazzarin; G Pantaleo
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 2.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania.

Authors:  Daudi R Mavura; E John Masenga; Eli Minja; Henning Grossmann; John A Crump; John A Bartlett
Journal:  Int J Dermatol       Date:  2014-09-26       Impact factor: 2.736

4.  Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.

Authors:  Esteban Ribera; Rosa M Lopez; Marjorie Diaz; Leonor Pou; Lidia Ruiz; Vicenç Falcó; Manuel Crespo; Carlos Azuaje; Isabel Ruiz; Imma Ocaña; Bonaventura Clotet; Albert Pahissa
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients.

Authors:  N M Ferguson; C A Donnelly; J Hooper; A C Ghani; C Fraser; L M Bartley; R A Rode; P Vernazza; D Lapins; S L Mayer; R M Anderson
Journal:  J R Soc Interface       Date:  2005-09-22       Impact factor: 4.118

Review 6.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

8.  Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.

Authors:  David J Feola; Beth A Garvy
Journal:  Clin Vaccine Immunol       Date:  2006-02

9.  Improving health outcomes for IPV-exposed women living with HIV.

Authors:  Gina M Wingood; Ralph J DiClemente; Puja Seth
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

10.  When to Start Antiretroviral Therapy and What to Start With-- A European Perspective.

Authors:  Ferdinand W.N.M. Wit; Peter Reiss
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.663
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.